Announcements Trials
Browse Landscape

Phase

Phase 1/2 1Phase 1 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Squamous Cell Carcinoma of Head and Neck 2Neoplasms 2Vascular Diseases 1Pathologic Processes 1Paraproteinemias 1Pancreatic Neoplasms 1Neoplastic Processes 1Neoplasms, Plasma Cell 1Neoplasms by Site 1Neoplasms by Histologic Type 1Neoplasm Metastasis 1Multiple Myeloma 1Lymphoproliferative Disorders 1Lymphoma 1Lymphatic Diseases 1Liver Neoplasms 1Liver Diseases 1Leukemia, Myeloid, Acute 1Immunoproliferative Disorders 1Hemorrhagic Disorders 1Hematologic Diseases 1Gliosarcoma 1Glioblastoma 1Digestive System Neoplasms 1Digestive System Diseases 1Cardiovascular Diseases 1Carcinoma 1Blood Protein Disorders 1

Interventions

Nivolumab 3osimertinib 2Pemetrexed 2Cetuximab 2Carboplatin 2spartalizumab 1napabucasin 1guadecitabine 1gallium 68 PSMA-11 1ficlatuzumab 1exemestane 1entinostat 1dostarlimab 1darolutamide 1apalutamide 1abexinostat 1Tyrosine Kinase Inhibitors 1Ramucirumab 1Radiosurgery 1Paclitaxel 1Leucovorin 1Irinotecan 1Interleukin-2 1Indocyanine Green 1HuMax-IL8 1Granulocyte-Macrophage Colony-Stimulating Factor 1Gemcitabine 1Fulvestrant 1Fluorouracil 1Erlotinib Hydrochloride 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 1 × Neoplasms by Site × ficlatuzumab × Clear all
NCT00969410 2012-04-12

A Pharmacodynamic Study of AV-299 (Formerly SCH 900105) in Subjects With Advanced Solid Tumors Who Have Liver Metastases

AVEO Pharmaceuticals, Inc.

Phase 1 Completed
19 enrolled
Gastrointestinal

Digestive System Diseases, Digestive System Neoplasms, Liver Diseases, Liver Neoplasms, Neoplasm Metastasis, Neoplasms, Neoplasms by Site, Neoplastic Processes, Pathologic Processes

Data powered by HemOnc (CC BY 4.0) Colophon âš¡